New MRI dye tested against standard for clearer kidney scans
NCT ID NCT07040865
Summary
This study compares a new MRI contrast agent called gadopiclenol against the standard agent gadobutrol to see if they work equally well for imaging kidney and adrenal findings. Participants will be randomly assigned to receive one of the two agents during a single 60-minute MRI scan. The goal is to determine if the new agent provides equally clear images to help doctors better evaluate incidental findings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUSPECT RENAL AND ADRENAL IMAGING FINDINGS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Diagnostic, Interventional and Pediatric Radiology Inselspital, University of Bern
RECRUITINGBern, 3010, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.